China biotech taps Big Data as next weapon against cancer
Entrepreneurs and scientists are also aiming to dominate the market for complex new procedures
Fri, Feb 10, 2017 - 5:50 AM
WHEN Nisa Leung was pregnant with her first child in 2012, her doctor in Hong Kong offered her a choice. She could take a prenatal test that would require inserting a needle into her uterus, or pay US$130 more for an exam that would draw a little blood from her arm.